Unlock instant, AI-driven research and patent intelligence for your innovation.
Vaccine for preventing swine transmissible gastroenteritis
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
An infectious and gastroenteritis technology, applied in the field of genetic engineering, can solve problems such as poor immunogenicity, and achieve the effects of excellent clinical application prospects, good safety and strong protection.
Active Publication Date: 2015-07-01
SICHUAN AGRI UNIV
View PDF1 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0067] Embodiment 1 Construction of recombinant bacteria of the present invention
[0070] 1.1 RT-PCR amplification of S gene and N gene
[0071] According to the S gene sequence of TGEV, a pair of primers were designed to amplify the 5’-1kb antigenic region of the S gene (named Sa, including four antigenic sites A, B, C, and D), and the upstream primer S1: 5’-CG GCTAGC ACCATGGAAAAACTATTTG-3', introduce restriction site NheI; downstream primer S2: 5'-CC AAGCTT TTAGCCACTAAGTAGCGTC-3', introduce restriction siteHindIII. Design a pair of primers according to the N gene sequence, the expected amplification length is, upstream primer N1: 5'-CG GAATTC AAAATGGCCAACCAGGGAC-3', introduce restriction siteEcoRI; downstream primer N2: 5'-CC CTCGAG AAGACGAGCATCTC-3', the restriction site XhoI was introduced.
[0072] Take TGEV cell culture virus liquid, extract viral RNA according to th...
experiment example 1
[0130] Experimental example 1 Characteristic identification and protective detection of recombinant attenuated Salmonella of the present invention
[0131] 1. Experimental method
[0132] Get the recombinant Salmonella SL7207 (pVAX-S) prepared in Example 1 499-650 ), according to the following method for identification:
[0133] 1 Identification of biological characteristics of strain SL7207 (pVAXD-N-Sa)
[0135]SL7207(pVAXD-N-Sa) and control strains SL7207(pVAX-S), SL7207(pVAX-N), SL7207(pVAX-S-N) and SL7207(pVAXD) were respectively streaked on LB plates containing 100 μg / mL Kan, Cultivate for 16 hours, pick a single colony, inoculate 5 mL of LB liquid medium containing 100 μg / mL Kan, culture at 37 °C, shake at 300 r / min until the OD600 is about 0.6, take the bacterial liquid for Gramstaining and microscopic examination, observe and record the bacteria form. ...
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Login to View More
Abstract
The invention discloses an application of recombinant salmonella containing nucleotide sequences shown in SEQ ID NO: 1 and SEQ ID NO: 2 in preparation for a medicine for preventing swine transmissible gastroenteritis, and further discloses a vaccine for preventing swine transmissible gastroenteritis, which is prepared from recombinant salmonella containing nucleotide sequences shown in SEQ ID NO: 1 and SEQ ID NO: 2, and pharmaceutically acceptable auxiliary materials or carriers. The vaccine disclosed by the invention is capable of inducibly producing two specific antibodies with regard to the S-protein and the N-protein of swine transmissible gastroenteritisvirus (TGEV) simultaneously, has a double-geneimmunologic function, a more comprehensive immunologic effect and a high level of the induced antibodies, as well as is capable of providing a more comprehensive protection function for swine transmissible gastroenteritis and excellent in clinical application prospect.
Description
technical field [0001] The invention relates to the field of genetic engineering, in particular to a vaccine for preventing porcine transmissible gastroenteritis. Background technique [0002] Porcine transmissible gastroenteritis (TGE) is a highly contagious intestinal infectious disease of pigs caused by porcine transmissible gastroenteritisvirus (TGEV). , diarrhea and dehydration death, pigs of different breeds and ages are susceptible to the disease, especially the mortality rate of piglets within 2 weeks of age can be as high as 100%. Since 2010, intractable diarrhea in piglets has occurred in a large area of pig herds in my country, and TGEV is one of the main pathogens frequently detected. [0003] At present, most of them are traditional inactivated vaccines and attenuated vaccines, but they have the risk of strong virulence and loose poison, which needs to be improved. In order to develop a porcine epidemic diarrhea vaccine that is safer, more efficient, less e...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.